NOVN Dividend History & Description — Novan Inc
Novan is a medical dermatology company focused on developing and commercializing therapeutic products for skin diseases. Co. is developing SB206 (berdazimer gel, 10.3%) as a topical prescription gel for the treatment of viral skin infections, with a focus on molluscum contagiosum. Co.'s commercial portfolio includes six prescription drugs. These prescription dermatology therapies are targeted to patients with plaque psoriasis, rosacea, and acne. The product portfolio includes Wynzora Cream (calcipotriene and betamethasone dipropionate cream), Rhofade (oxymetazoline hydrochloride cream, 1%), and Minolira (biphasic minocycline hydrochloride immediate release/extended release tablets). When considering the Novan Inc stock dividend history, we have taken known splits into account, such that the NOVN dividend history is presented on a split-adjusted ("apples to apples") basis. Novan Inc dividend history is presented both in graphical/chart form, and as a NOVN dividend history data table along the right-hand column.